Trellus Health Statistics

Total Valuation

Trellus Health has a market cap or net worth of GBP 1.07 million. The enterprise value is -73,385.

Market Cap	1.07M
Enterprise Value	-73,385

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Trellus Health has 186.28 million shares outstanding.

Current Share Class	186.28M
Shares Outstanding	186.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.96%
Owned by Institutions (%)	63.03%
Float	117.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.09
PB Ratio	0.17
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.01
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.63

Current Ratio	3.63
Quick Ratio	3.63
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.65% and return on invested capital (ROIC) is -35.92%.

Return on Equity (ROE)	-56.65%
Return on Assets (ROA)	-34.37%
Return on Invested Capital (ROIC)	-35.92%
Return on Capital Employed (ROCE)	-80.27%
Weighted Average Cost of Capital (WACC)	18.93%
Revenue Per Employee	14,557
Profits Per Employee	-279,308
Employee Count	18
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.62% in the last 52 weeks. The beta is 2.67, so Trellus Health's price volatility has been higher than the market average.

Beta (5Y)	2.67
52-Week Price Change	-72.62%
50-Day Moving Average	0.63
200-Day Moving Average	0.78
Relative Strength Index (RSI)	45.28
Average Volume (20 Days)	6,691,001

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Trellus Health had revenue of GBP 262,034 and -5.03 million in losses. Loss per share was -0.03.

Revenue	262,034
Gross Profit	262,034
Operating Income	-5.10M
Pretax Income	-5.03M
Net Income	-5.03M
EBITDA	-5.06M
EBIT	-5.10M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 1.14 million in cash and n/a in debt, with a net cash position of 1.14 million or 0.01 per share.

Cash & Cash Equivalents	1.14M
Total Debt	n/a
Net Cash	1.14M
Net Cash Per Share	0.01
Equity (Book Value)	6.35M
Book Value Per Share	0.04
Working Capital	984,635

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.49M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,946.52%
Pretax Margin	-1,918.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Trellus Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-469.38%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Trellus Health has an Altman Z-Score of -3.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.88
Piotroski F-Score	2